Tahli Fenner, PhD

Director or Risk Management Section
Department of Health, Australia

Dr Tahli Fenner is the Director of the Risk Management Section, within the Pharmacovigilance Branch of the TGA, which is responsible for managing the clinical trial notification and approval schemes, as well as the pharmacovigilance and Good Clinical Practice inspection programs and risk management plan evaluation. Dr Fenner joined the TGA after completing her PhD in synthetic organic chemistry. She has worked across many different areas within the TGA and the Department of Health, since starting out in medicines evaluation. Her more recent roles within the TGA have included leading the teams responsible for managing medicines scheduling and expert advisory committees.

Related Sessions

View full schedule